We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

168 hedge funds and large institutions have $1.57B invested in Amedisys in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 67 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $3.14M | Put options by funds: $2.07M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

7% more capital invested

Capital invested by funds: $1.46B → $1.57B (+$108M)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 169168 (-1)

12% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 67

Holders
168
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
4.48%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
59
Reduced
67
Closed
21
Calls
$3.14M
Puts
$2.07M
Net Calls
+$1.07M
Net Calls Change
+$3.32M
Name Holding Trade Value Shares
Change
Change in
Stake
LIA
151
LS Investment Advisors
Michigan
$59K +$2.22K +44 +4%
AG
152
Advisor Group
Arizona
$57K +$57.9K +1,147 New
Creative Planning
153
Creative Planning
Kansas
$55K -$1.01K -20 -2%
SNT
154
Security National Trust
West Virginia
$50K +$50.5K +1,000 New
Zurich Cantonal Bank
155
Zurich Cantonal Bank
Switzerland
$34K
Fuller & Thaler Asset Management
156
Fuller & Thaler Asset Management
California
$30K +$30.3K +600 New
BWP
157
Baldwin Wealth Partners
Massachusetts
$28K +$2.73K +54 +11%
SWA
158
Sutton Wealth Advisors
Florida
$24.2K
RAM
159
Riggs Asset Management
Pennsylvania
$23K
VCM
160
Versant Capital Management
Arizona
$21K -$555 -11 -3%
QT
161
Quantbot Technologies
New York
$16K +$16.7K +330 New
PNC Financial Services Group
162
PNC Financial Services Group
Pennsylvania
$9K -$353 -7 -4%
TRCT
163
Tower Research Capital (TRC)
New York
$6K +$5.6K +111 New
GXMC
164
Global X Management Company
New York
$5K +$4.64K +92 New
TWA
165
TCI Wealth Advisors
Arizona
$3K
LTFS
166
Ladenburg Thalmann Financial Services
Florida
$2K
MWP
167
MYCIO Wealth Partners
Pennsylvania
$2K +$1.92K +38 New
QCG
168
Quadrant Capital Group
Ohio
$1K +$2.07K +41 New
NTC
169
North Tide Capital
Massachusetts
-$24.2M -500,000 Closed
EAM
170
EverPoint Asset Management
Connecticut
-$7.49M -155,000 Closed
Adage Capital Partners
171
Adage Capital Partners
Massachusetts
-$4.83M -100,000 Closed
Point72 Asset Management
172
Point72 Asset Management
Connecticut
-$4.44M -91,900 Closed
Two Sigma Investments
173
Two Sigma Investments
New York
-$3.4M -70,279 Closed
ARTA
174
A.R.T. Advisors
New York
-$2.45M -50,626 Closed
FQ
175
First Quadrant
California
-$1.53M -31,600 Closed

AMED Hedge Fund Activity: Q2 2016 in Review

168 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2016, worth a combined $1.57B — up 7.4% from $1.46B a quarter earlier.

Fund positioning in AMED was balanced in Q2 2016: 21 funds opened new positions, 21 closed out, 59 added to existing stakes and 67 trimmed.

The largest buyer was Wells Fargo, adding an estimated $79.1M. The largest seller was North Tide Capital, exiting entirely with an estimated $24.2M sold.

  • 168 institutional investors held Amedisys (AMED) as of Q2 2016, down from 169 in Q1 2016.
  • Funds reported $1.57B of Amedisys stock for Q2 2016, up 7.4% quarter-over-quarter.
  • 21 funds opened new Amedisys positions in Q2 2016 and 21 closed out, a net change of 0 holders.
  • The largest Amedisys buyer in Q2 2016 was Wells Fargo, an estimated $79.1M added.
  • The largest Amedisys seller in Q2 2016 was North Tide Capital, an estimated $24.2M sold.

Based on aggregated 13F filings for Q2 2016.